Unilever Seeks End To Litigation Over St. Ives Scrub, Plaintiffs’ ‘Fake Medical Condition’

In April 2017, Unilever failed to dismiss a putative class action in California’s Central District alleging that its St. Ives Apricot Scrub is unfit for sale due to the potential of its crushed walnut shells to cause “microtears” in skin. Now the firm seeks summary judgment in the matter, maintaining that plaintiffs are relying on “junk science” to assert the possibility of a made-up medical condition.

Gavel

Kaylee Browning et al v. Unilever is a case to follow in California’s Central District, if for no other reason than it makes for highly entertaining reading.

For that there is Unilever counsel to thank.

More from Legal

More from Policy & Regulation

Cloudy Tariff Conditions Expected To Linger In US

 

White House announces president extends deadline he set in April for other countries to make new tariff deals from July 9 to Aug. 1, when the administration will start sending letters warning other countries that higher tariffs could take effect.

US FDA’s Tough Talk On Talc: Regulating In An Echo Chamber

 

An FDA “expert roundtable” on talc produced a new talking point on a potential drug safety risk, but the basis of that claim is difficult to determine.

ECHA Adds Two Cosmetic/Personal Care Silicones To REACH Candidate List

 

ECHA has added two silicone ingredients used in cosmetics and personal care products to the REACH Candidate List as they are persistent and have bioaccumulative properties, requiring companies to notify customers and update safety data sheets if concentrations exceed 0.1%.